BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10944585)

  • 1. The puzzling multiple lives of PML and its role in the genesis of cancer.
    Ruggero D; Wang ZG; Pandolfi PP
    Bioessays; 2000 Sep; 22(9):827-35. PubMed ID: 10944585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in researches on the function of PML gene].
    Zhou L; Chen G; Shen Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):132-5. PubMed ID: 10751540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
    Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
    J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research progress in cytoplasmic PML gene functions].
    Xu XH; Sun YY; Zhang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):857-60. PubMed ID: 24989309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The function of PML in p53-dependent apoptosis.
    Guo A; Salomoni P; Luo J; Shih A; Zhong S; Gu W; Pandolfi PP
    Nat Cell Biol; 2000 Oct; 2(10):730-6. PubMed ID: 11025664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
    Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
    Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML.
    Cao T; Duprez E; Borden KL; Freemont PS; Etkin LD
    J Cell Sci; 1998 May; 111 ( Pt 10)():1319-29. PubMed ID: 9570750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
    Testa U; Grignani F; Barberi T; Fagioli M; Masciulli R; Ferrucci PF; Seripa D; Camagna A; Alcalay M; Pelicci PG
    Cancer Res; 1994 Aug; 54(16):4508-15. PubMed ID: 7519122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.
    Doucas V; Tini M; Egan DA; Evans RM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2627-32. PubMed ID: 10077561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biologic function of PML and its role in acute promyelocytic leukemia.
    Mu ZM; Le XF; Glassman AB; Chang KS
    Leuk Lymphoma; 1996 Oct; 23(3-4):277-85. PubMed ID: 9031108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PML nuclear compartment and cancer.
    Doucas V; Evans RM
    Biochim Biophys Acta; 1996 Dec; 1288(3):M25-9. PubMed ID: 9011178
    [No Abstract]   [Full Text] [Related]  

  • 13. PML is essential for multiple apoptotic pathways.
    Wang ZG; Ruggero D; Ronchetti S; Zhong S; Gaboli M; Rivi R; Pandolfi PP
    Nat Genet; 1998 Nov; 20(3):266-72. PubMed ID: 9806545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for PML and the nuclear body in genomic stability.
    Zhong S; Hu P; Ye TZ; Stan R; Ellis NA; Pandolfi PP
    Oncogene; 1999 Dec; 18(56):7941-7. PubMed ID: 10637504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
    Gambacorta M; Flenghi L; Fagioli M; Pileri S; Leoncini L; Bigerna B; Pacini R; Tanci LN; Pasqualucci L; Ascani S; Mencarelli A; Liso A; Pelicci PG; Falini B
    Am J Pathol; 1996 Dec; 149(6):2023-35. PubMed ID: 8952536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of promyelocytic leukemia (PML) protein in tumor suppression.
    Rego EM; Wang ZG; Peruzzi D; He LZ; Cordon-Cardo C; Pandolfi PP
    J Exp Med; 2001 Feb; 193(4):521-29. PubMed ID: 11181703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
    Lai HK; Borden KL
    Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
    Grignani F; Testa U; Fagioli M; Barberi T; Masciulli R; Mariani G; Peschle C; Pelicci PG
    Cancer Res; 1995 Jan; 55(2):440-3. PubMed ID: 7529139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.